World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9781786344946_0008Cited by:0 (Source: Crossref)
Abstract:

The following sections are included:

  • An aneurysm is an abnormal dilatation of a vessel to greater than 50% normal size.

  • Smoking, male gender, hypertension and genetics are the main risk factors for abdominal aortic aneurysm (AAA).

  • The annual risk of rupture for an AAA of 5–5.9 cm is 5%.

  • Contrast enhanced tomography (computed tomography, CT) is the gold standard for measuring the size of an aneurysm and planning intervention.

  • The UK small aneurysm trial (UKSAT) helped reach a consensus about the minimal size at which aneurysms should be treated — usually 5.5 cm in the UK.

  • The UK endovascular aneurysm repair trial (EVAR) 1 showed better early results for EVAR vs. open surgery, although after 2 years there was no benefit and at 15 years EVAR was inferior.

  • The UK EVAR 2 trial in unfit patients showed no difference between endovascular and open repair in unfit patients.

  • The IMPROVE, AJAX and the ECAR trials showed similar mortality for endovascular vs. open repair for ruptured aortic aneurysms.